Matching slides 118,578
Current window 100,351-100,380
Pages 3,953
Rows per page 30
Component: Paragraphclear collectionreset all

Component

100,351-100,380 of 118,578

filter-aware
04
Uses a process diagram to show the 'loop' of optimization (affinity, developability, toxicity) leading to suboptimal outcomes.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a high-contrast metaphor to frame the company's value proposition. The background includes a faint, real-world lab setting with a process diagram on a whiteboard.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a dot plot to show search space diversity and a bar chart to compare binding rates against various baselines.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
19
The slide demonstrates that Variant A* shows higher potency than the wild-type trastuzumab in both binding and ADCC assays.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
23
The slide highlights the challenge of binding affinity (Kd) for the beta variant (607 nM) compared to others, using molecular visualization of RBD mutations.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses a process diagram to explain the technical methodology of Absci's drug discovery platform.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a process flow (1: Data generation, 2: Model training) followed by validation results (scatter plot and correlation table).Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
26
SPR stands for Surface Plasmon Resonance, a standard technique for measuring binding affinity.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
33
Includes a Kaplan-Meier survival curve as evidence for the clinical relevance of TLS.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
01
Slide 1
Includes branding for argenx and the ADDRESS study.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Attention1 hit
06
The slide outlines a clinical trial protocol using a process flow diagram.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations 1 hit
01
Slide 1
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
03
The slide uses a structured list format to present key company pillars.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
08
The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solves.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a horizontal bar chart to represent progress through Research, Development, Clinical Testing, and Regulatory stages.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Includes a specific capital requirement estimate at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a bottom-up market sizing approach based on patient volumes and testing frequency.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
01
Slide 1
Vivid Seats | Results Presentation Deck | 22 slidesVivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
04
Vivid Seats | Results Presentation Deck | 22 slidesVivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
06
Vivid Seats | Results Presentation Deck | 22 slidesVivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a checkmark matrix to validate the strategic rationale for two specific M&A deals.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
Vivid Seats | Results Presentation Deck | 22 slidesVivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
The chart shows a consistent upward trend in both GOV and Revenue over the 7-quarter period.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
15
Vivid Seats | Results Presentation Deck | 22 slidesVivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
18
Vivid Seats | Results Presentation Deck | 22 slidesVivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
22
The table includes footnotes explaining specific line items like sales tax liability, transaction costs, and various fair value adjustments.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
01
Slide 1
The slide displays seven distinct brand logos/images: Perfect Diary, Little Ondine, Pink Bear, Dr. Wu, Galénic, Eve Lom, and Abby's Choice.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations 1 hit
05
Data sourced from China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide highlights a shift in revenue mix towards skincare brands despite a slight YoY decline in absolute revenue.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit